Advertisement
Screener

Avantor, Inc. (AVTR) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax

1.9 / 5 stars · 29/75 Roast Me

Avantor, Inc. Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax

Avantor, Inc. (AVTR) reported Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax of $28.10 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-07.

Financial Statements › Notes › Equity › Stockholders' Equity Note

us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax · last filed 2025-02-07

  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2024-12-31 was -$2.90M, a 120.14% decline year-over-year.
  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2024-09-30 was $14.10M, a 67.86% increase year-over-year.
  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2024-06-30 was $8.40M, a 10.53% increase year-over-year.
  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for the quarter ending 2024-03-31 was $8.50M, a 30.77% increase year-over-year.
  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2024 was $28.10M, a 23.85% decline from fiscal 2023.
  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2023 was $36.90M, a 339.29% increase from fiscal 2022.
  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2022 was $8.40M.
  • Avantor, Inc. reclassification from accumulated other comprehensive income, current period, before tax for fiscal 2021 was -$3.60M, a 427.27% decline from fiscal 2020.
Period endReclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 3 monthReclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 3 month as first filedReclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 6 monthReclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 6 month as first filedReclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 9 monthReclassification from Accumulated Other Comprehensive Income, Current Period, before Tax 12 month
2024-12-31-$2.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07
$11.20M
derived: sum of 2 quarters · filed 2025-02-07
$19.60M
derived: sum of 3 quarters · filed 2025-02-07
$28.10M
10-K · filed 2025-02-07
2024-09-30$14.10M
10-Q · filed 2024-10-25
$22.50M
derived: sum of 2 quarters · filed 2024-10-25
$31.00M
10-Q · filed 2024-10-25
$45.40M
derived: sum of 4 quarters · filed 2025-02-07
2024-06-30$8.40M
10-Q · filed 2024-07-26
$16.90M
10-Q · filed 2024-07-26
$31.30M
derived: sum of 3 quarters · filed 2025-02-07
$39.70M
derived: sum of 4 quarters · filed 2025-02-07
2024-03-31$8.50M
10-Q · filed 2024-04-26
$22.90M
derived: sum of 2 quarters · filed 2025-02-07
$31.30M
derived: sum of 3 quarters · filed 2025-02-07
$38.90M
derived: sum of 4 quarters · filed 2025-02-07
2023-12-31$14.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07
$22.80M
derived: sum of 2 quarters · filed 2025-02-07
$30.40M
derived: sum of 3 quarters · filed 2025-02-07
$36.90M
10-K · filed 2025-02-07
2023-09-30$8.40M
10-Q · filed 2024-10-25
$16.00M
derived: sum of 2 quarters · filed 2024-10-25
$22.50M
10-Q · filed 2024-10-25
$29.60M
derived: sum of 4 quarters · filed 2025-02-07
2023-06-30$7.60M
10-Q · filed 2024-07-26
$14.10M
10-Q · filed 2024-07-26
$21.20M
derived: sum of 3 quarters · filed 2025-02-07
$21.10M
derived: sum of 4 quarters · filed 2025-02-07
2023-03-31$6.50M
10-Q · filed 2024-04-26
$13.60M
derived: sum of 2 quarters · filed 2025-02-07
$13.50M
derived: sum of 3 quarters · filed 2025-02-07
$14.60M
derived: sum of 4 quarters · filed 2025-02-07
2022-12-31$7.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07
$7.00M
derived: sum of 2 quarters · filed 2025-02-07
$8.10M
derived: sum of 3 quarters · filed 2025-02-07
$8.40M
10-K · filed 2025-02-07
2022-09-30-$100.00K
10-Q · filed 2023-10-27
$1.00M
derived: sum of 2 quarters · filed 2023-10-27
$1.30M
10-Q · filed 2023-10-27
$700.00K
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$1.10M
10-Q · filed 2023-07-28
$1.40M
10-Q · filed 2023-07-28
$800.00K
derived: sum of 3 quarters · filed 2024-02-14
-$100.00K
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$300.00K
10-Q · filed 2023-04-28
-$300.00K
derived: sum of 2 quarters · filed 2024-02-14
-$1.20M
derived: sum of 3 quarters · filed 2024-02-14
-$2.50M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31-$600.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
-$1.50M
derived: sum of 2 quarters · filed 2024-02-14
-$2.80M
derived: sum of 3 quarters · filed 2024-02-14
-$3.60M
10-K · filed 2024-02-14
2021-09-30-$900.00K
10-Q · filed 2022-10-28
-$2.20M
derived: sum of 2 quarters · filed 2022-10-28
-$3.00M
10-Q · filed 2022-10-28
-$3.60M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30-$1.30M
10-Q · filed 2022-07-29
-$2.60M
10-Q · filed 2022-07-29
-$2.70M
derived: sum of 3 quarters · filed 2023-02-14
-$1.90M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31-$700.00K
10-Q · filed 2022-04-29
-$1.40M
derived: sum of 2 quarters · filed 2023-02-14
-$600.00K
derived: sum of 3 quarters · filed 2023-02-14
$400.00K
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31-$700.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$100.00K
derived: sum of 2 quarters · filed 2023-02-14
$1.10M
derived: sum of 3 quarters · filed 2023-02-14
$1.10M
10-K · filed 2023-02-14
2020-09-30$800.00K
10-Q · filed 2021-10-29
$1.80M
derived: sum of 2 quarters · filed 2021-10-29
$1.80M
10-Q · filed 2021-10-29
$1.80M
derived: sum of 4 quarters · filed 2022-02-11
2020-06-30$1.00M
10-Q · filed 2021-07-30
$800.00K
10-Q · filed 2020-07-29
$800.00K
10-Q · filed 2021-07-30
$1.00M
10-Q · filed 2020-07-29
$1.00M
derived: sum of 3 quarters · filed 2022-02-11
$2.10M
derived: sum of 4 quarters · filed 2022-02-11
2020-03-31$200.00K
10-Q · filed 2021-04-28
$0.00
derived: sum of 2 quarters · filed 2022-02-11
$1.10M
derived: sum of 3 quarters · filed 2022-02-11
$1.20M
derived: sum of 4 quarters · filed 2022-02-11
2019-12-31-$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11
$900.00K
derived: sum of 2 quarters · filed 2022-02-11
$1.00M
derived: sum of 3 quarters · filed 2022-02-11
$1.50M
10-K · filed 2022-02-11
2019-09-30$1.10M
10-Q · filed 2020-10-27
$1.20M
derived: sum of 2 quarters · filed 2020-10-27
$1.70M
10-Q · filed 2020-10-27
-$400.00K
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$100.00K
10-Q · filed 2020-07-29
$600.00K
10-Q · filed 2020-07-29
-$1.50M
derived: sum of 3 quarters · filed 2021-02-16
-$700.00K
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$500.00K
10-Q · filed 2020-04-29
-$1.60M
derived: sum of 2 quarters · filed 2021-02-16
-$800.00K
derived: sum of 3 quarters · filed 2021-02-16
-$500.00K
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31-$2.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
-$1.30M
derived: sum of 2 quarters · filed 2021-02-16
-$1.00M
derived: sum of 3 quarters · filed 2021-02-16
-$400.00K
10-K · filed 2021-02-16
2018-09-30$800.00K
10-Q · filed 2019-11-05
$1.10M
derived: sum of 2 quarters · filed 2019-11-05
$1.70M
10-Q · filed 2019-11-05
2018-06-30$300.00K
10-Q · filed 2019-08-06
$900.00K
10-Q · filed 2019-08-06
2017-12-31$3.10M
10-K · filed 2020-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRUKER CORP (BRKR)United States$9.706B-128.75
REVVITY, INC. (RVTY)United States$16.814B53.44
Alamar Biosciences, Inc. (ALMR)United States$2.300B
Cytek Biosciences, Inc. (CTKB)United States$0.744B-7.15
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)United States$0.491B-3.95
908 Devices Inc. (MASS)United States$0.476B-9.53
EyePoint, Inc. (EYPT)United States$0.314B-3.96
Quanterix Corp (QTRX)United States$0.150B-1.65
Nautilus Biotechnology, Inc. (NAUT)United States$0.129B-4.16
Seer, Inc. (SEER)United States$0.104B-1.34